SCHEMBL7125963

SCHEMBL7125963

O=C(O)c1c(Cl)c(Cl)c(Cl)c(Cl)c1-c1c2ccc(=O)c(O)c-2oc2c(O)c(O)ccc12

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GNG2 P59768 9/20 0.61
GNB1 P62873 9/20 0.61
HPGD P15428 5/20 0.55
HSPA1A P0DMV8 4/20 0.55
HSPA8 P11142 4/20 0.55
ALOX15 P16050 4/20 0.55
HSD17B10 Q99714 4/20 0.55
BRCA1 P38398 3/20 0.55
CYP2C9 P11712 3/20 0.55
CYP2C19 P33261 3/20 0.55
GAPDH P04406 1/20 0.55
RAPGEF4 Q8WZA2 1/20 0.55
MAPK1 P28482 1/20 0.55
KDM4A O75164 1/20 0.55
USP2 O75604 1/20 0.55
NSD2 O96028 1/20 0.55
ALPL P05186 1/20 0.55
PLCG1 P19174 1/20 0.55
TNNI3 P19429 1/20 0.55
NFKB1 P19838 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26197590 0.83 HPGD (0.55) GNG2GNB1HPGDHSPA1AHSPA8
SCHEMBL2777698 0.77 GNG2 (0.69) GNG2GNB1HPGDHSPA1AHSPA8
SCHEMBL2848109 0.77 GNG2 (0.65) GNG2GNB1HPGDHSPA1AHSPA8
SCHEMBL13352283 0.76 GNG2 (0.71) GNG2GNB1HPGDHSPA1AHSPA8
SCHEMBL2777300 0.76 GNG2 (1.00) GNG2GNB1HPGDHSPA1AHSPA8
SCHEMBL1444942 0.75 MEN1 (0.76) GNG2GNB1HPGDHSPA1AHSPA8
SCHEMBL2840949 0.74 GNG2 (0.64) GNG2GNB1HPGDHSPA1AHSPA8
SCHEMBL1444584 0.73 PARG (0.76) GNG2GNB1HPGDALDH1A1MEN1
SCHEMBL2779337 0.72 GNG2 (1.00) GNG2GNB1HPGDHSPA1AHSPA8
SCHEMBL2846330 0.71 GNG2 (1.00) GNG2GNB1HPGDHSPA1AHSPA8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2002062333-A9 USE OF 9H-XANTHENES IN A METHOD OF INHIBITING VIRAL REPLICATION TARGETING THE NUCLEOCAPSID PROTEIN US GOV HEALTH & HUMAN SERV (US) 2003-01-30 WO disclosed
WO-2002062333-A1 USE OF 9H-XANTHENES IN A METHOD OF INHIBITING VIRAL REPLICATION TARGETING THE NUCLEOCAPSID PROTEIN THE GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2002-08-15 WO disclosed